Biofrontera (BFRI) Short-term Investments (2022 - 2025)

Biofrontera's Short-term Investments history runs 4 years deep, the most recent figure standing at $9000.0 for Q4 2025.

• On a quarterly basis, Short-term Investments rose 28.57% year-over-year to $9000.0 in Q4 2025; TTM through Dec 2025 was $9000.0, a 28.57% increase from a year earlier, with the FY2025 full-year figure at $9000.0, up 28.57% from the prior year.
• Short-term Investments fell to $9000.0 in Q4 2025 per BFRI's latest filing, from $10000.0 in the prior quarter.
• Across five years, Short-term Investments topped out at $10.5 million in Q4 2022 and bottomed at $7000.0 in Q4 2024.
• The 4-year median for Short-term Investments is $10000.0 (2024), against an average of $1.8 million.
• Across the five-year window, Short-term Investments plunged 99.76% in 2024 and rose 28.57% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $10.5 million in 2022, then tumbled by 99.26% to $78000.0 in 2023, then slumped by 91.03% to $7000.0 in 2024, then advanced by 28.57% to $9000.0 in 2025.
• Per Business Quant, the three latest BFRI Short-term Investments figures stand at $9000.0 (Q4 2025), $10000.0 (Q3 2025), and $9000.0 (Q2 2025).